CN102743557A - 一种治疗血热型慢性子宫颈炎的中药冲洗剂制备方法 - Google Patents
一种治疗血热型慢性子宫颈炎的中药冲洗剂制备方法 Download PDFInfo
- Publication number
- CN102743557A CN102743557A CN2012101986108A CN201210198610A CN102743557A CN 102743557 A CN102743557 A CN 102743557A CN 2012101986108 A CN2012101986108 A CN 2012101986108A CN 201210198610 A CN201210198610 A CN 201210198610A CN 102743557 A CN102743557 A CN 102743557A
- Authority
- CN
- China
- Prior art keywords
- grams
- herba
- radix
- gram
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 206010008323 cervicitis Diseases 0.000 title claims abstract description 21
- 201000003988 chronic cervicitis Diseases 0.000 title claims abstract description 21
- 229940113601 irrigation solution Drugs 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 claims abstract description 16
- 239000010231 banlangen Substances 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 7
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 6
- 241000628997 Flos Species 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 241001199012 Usta Species 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- 229940056582 human hair preparation Drugs 0.000 claims description 5
- 239000003643 water by type Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 241000205585 Aquilegia canadensis Species 0.000 abstract description 2
- 235000010662 Bidens pilosa Nutrition 0.000 abstract description 2
- 240000003690 Callicarpa japonica Species 0.000 abstract description 2
- 241001355283 Cayratia Species 0.000 abstract description 2
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 244000303199 Lamium album Species 0.000 abstract description 2
- 235000009199 Lamium album Nutrition 0.000 abstract description 2
- 241000123069 Ocyurus chrysurus Species 0.000 abstract description 2
- 241001448535 Reineckea carnea Species 0.000 abstract description 2
- 240000007164 Salvia officinalis Species 0.000 abstract description 2
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract description 2
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract description 2
- 239000003242 anti bacterial agent Substances 0.000 abstract description 2
- 229940088710 antibiotic agent Drugs 0.000 abstract description 2
- 239000004071 soot Substances 0.000 abstract description 2
- 241000288784 Barleria cristata Species 0.000 abstract 1
- 244000104272 Bidens pilosa Species 0.000 abstract 1
- 241000729173 Cirsium japonicum Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000015456 Japanese beauty berry Nutrition 0.000 abstract 1
- 241001071917 Lithospermum Species 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 241001092489 Potentilla Species 0.000 abstract 1
- 241001092459 Rubus Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 241000612118 Samolus valerandi Species 0.000 abstract 1
- 244000173853 Sanguisorba officinalis Species 0.000 abstract 1
- 241001146210 Senecio scandens Species 0.000 abstract 1
- 244000046101 Sophora japonica Species 0.000 abstract 1
- 235000010586 Sophora japonica Nutrition 0.000 abstract 1
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 239000002689 soil Substances 0.000 abstract 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 34
- 239000008280 blood Substances 0.000 description 34
- 210000004185 liver Anatomy 0.000 description 27
- 231100000614 poison Toxicity 0.000 description 24
- 239000003440 toxic substance Substances 0.000 description 22
- 230000023597 hemostasis Effects 0.000 description 21
- 238000001816 cooling Methods 0.000 description 19
- 210000004072 lung Anatomy 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 12
- 210000002216 heart Anatomy 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 208000004880 Polyuria Diseases 0.000 description 9
- 230000035619 diuresis Effects 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 210000002429 large intestine Anatomy 0.000 description 9
- 210000003679 cervix uteri Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 7
- 230000008961 swelling Effects 0.000 description 6
- 206010020880 Hypertrophy Diseases 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 229930182555 Penicillin Natural products 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 208000003455 anaphylaxis Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 229940049954 penicillin Drugs 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 206010008254 Cervical cyst Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 208000016369 nabothian cyst Diseases 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 229960004659 ticarcillin Drugs 0.000 description 3
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000037062 Polyps Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 2
- 206010037128 Pseudomembranous colitis Diseases 0.000 description 2
- 206010037549 Purpura Diseases 0.000 description 2
- 241001672981 Purpura Species 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 102000014898 transaminase activity proteins Human genes 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 241000143476 Bidens Species 0.000 description 1
- 244000157790 Buglossoides arvense Species 0.000 description 1
- 235000004256 Buglossoides arvense Nutrition 0.000 description 1
- 235000017595 Callicarpa japonica Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 240000001579 Cirsium arvense Species 0.000 description 1
- 235000005918 Cirsium arvense Nutrition 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011509 Crystalluria Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011894 Deafness permanent Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 244000286838 Eclipta prostrata Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000576429 Forsythia suspensa Species 0.000 description 1
- 206010018687 Granulocytopenia Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 235000013717 Houttuynia Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010061298 Mucosal haemorrhage Diseases 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 241001571466 Potentilla discolor Species 0.000 description 1
- 240000004064 Poterium sanguisorba Species 0.000 description 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 235000002912 Salvia officinalis Nutrition 0.000 description 1
- 240000003705 Senecio vulgaris Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 240000006688 Telosma cordata Species 0.000 description 1
- 235000017352 Telosma cordata Nutrition 0.000 description 1
- 240000008488 Thlaspi arvense Species 0.000 description 1
- 235000008214 Thlaspi arvense Nutrition 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 1
- 229960004682 cefoperazone Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 201000003505 cervical polyp Diseases 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 229940038649 clavulanate potassium Drugs 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 210000000860 cochlear nerve Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000000003 hoof Anatomy 0.000 description 1
- 239000003864 humus Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 238000012317 liver biopsy Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- ABVRVIZBZKUTMK-JSYANWSFSA-M potassium clavulanate Chemical compound [K+].[O-]C(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 ABVRVIZBZKUTMK-JSYANWSFSA-M 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000009910 sargent gloryvine Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
年龄(岁) | 26~30 | 31~40 | 41~50 | 51~60 |
例数 | 13 | 235 | 132 | 5 |
百分比 | 3.4% | 61% | 34.3% | 1.3% |
疗效 | 治愈 | 好转 | 无效 |
例数 | 382 | 3 | 无 |
百分比 | 99.2% | 0.8% | 无 |
治疗天数 | 3~5 | 6~9 | 10~14 | 15~21 |
例数 | 12 | 205 | 161 | 7 |
百分比 | 3.1% | 53.3% | 41.8% | 1.8% |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101986108A CN102743557B (zh) | 2012-06-17 | 2012-06-17 | 一种治疗血热型慢性子宫颈炎的中药冲洗剂制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101986108A CN102743557B (zh) | 2012-06-17 | 2012-06-17 | 一种治疗血热型慢性子宫颈炎的中药冲洗剂制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102743557A true CN102743557A (zh) | 2012-10-24 |
CN102743557B CN102743557B (zh) | 2013-08-21 |
Family
ID=47024286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101986108A Expired - Fee Related CN102743557B (zh) | 2012-06-17 | 2012-06-17 | 一种治疗血热型慢性子宫颈炎的中药冲洗剂制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102743557B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103110786A (zh) * | 2013-02-09 | 2013-05-22 | 王维萌 | 一种治疗外伤型球结膜下出血的中药制备方法 |
CN103110790A (zh) * | 2013-02-09 | 2013-05-22 | 李坚恩 | 一种治疗胸闷型球结膜下出血的中药制备方法 |
CN103110784A (zh) * | 2013-02-09 | 2013-05-22 | 赵相兰 | 一种治疗肝郁化火型巩膜炎的中药制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101850101A (zh) * | 2010-06-30 | 2010-10-06 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗漏下的中药组合物及其制备方法 |
-
2012
- 2012-06-17 CN CN2012101986108A patent/CN102743557B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101850101A (zh) * | 2010-06-30 | 2010-10-06 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗漏下的中药组合物及其制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103110786A (zh) * | 2013-02-09 | 2013-05-22 | 王维萌 | 一种治疗外伤型球结膜下出血的中药制备方法 |
CN103110790A (zh) * | 2013-02-09 | 2013-05-22 | 李坚恩 | 一种治疗胸闷型球结膜下出血的中药制备方法 |
CN103110784A (zh) * | 2013-02-09 | 2013-05-22 | 赵相兰 | 一种治疗肝郁化火型巩膜炎的中药制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102743557B (zh) | 2013-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102727768B (zh) | 一种治疗出血型老年性阴道炎的中药洗剂制备方法 | |
CN102743590B (zh) | 一种治疗糜烂型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743618B (zh) | 一种治疗尿道口烧灼型老年性阴道炎的中药洗剂制备方法 | |
CN102743557B (zh) | 一种治疗血热型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743556B (zh) | 一种治疗出血型霉菌性阴道炎中药洗剂的制备方法 | |
CN103099934B (zh) | 一种治疗气滞血瘀型急性乳腺炎的中药洗剂制备方法 | |
CN102641438A (zh) | 一种治疗热毒型臁疮的中药制备方法 | |
CN102743613B (zh) | 一种治疗胃阴亏虚型老年性阴道炎的中药洗剂制备方法 | |
CN102743616B (zh) | 一种治疗湿热型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743693B (zh) | 一种治疗腰骶坠胀型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743620B (zh) | 一种治疗热毒型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743692B (zh) | 一种治疗月经不调型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743564B (zh) | 一种治疗宫颈红肿型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743691B (zh) | 一种治疗肝经风热型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743723B (zh) | 一种治疗白带量多型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102727767B (zh) | 一种治疗渗出型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743725B (zh) | 一种治疗宫颈脱出型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743588B (zh) | 一种治疗腹痛型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743591B (zh) | 一种治疗疼痛型滴虫性阴道炎的中药洗剂制备方法 | |
CN102743526B (zh) | 一种治疗水肿型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743619B (zh) | 一种治疗脓水型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743617B (zh) | 一种治疗腰痛型慢性子宫颈炎的中药冲洗剂制备方法 | |
CN102743621B (zh) | 一种治宫颈粘膜息肉型慢性子宫颈炎中药冲洗剂制备方法 | |
CN102743611B (zh) | 一种治疗血虚型老年性阴道炎的中药洗剂制备方法 | |
CN102743447B (zh) | 一种治疗肾阳虚型老年性阴道炎的中药洗剂制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHANG WEI Free format text: FORMER OWNER: ZHENG TIANYING Effective date: 20130723 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Wei Inventor after: Feng Xiuyin Inventor before: Zheng Tiancheng |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250012 JINAN, SHANDONG PROVINCE TO: 274600 HEZE, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: ZHENG TIANYING TO: ZHANG WEI FENG XIUYIN |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130723 Address after: 274600 Juancheng people's Hospital, Heze, Shandong, China Applicant after: Zhang Wei Address before: 250012 Center for chemotherapy, Qilu Hospital,, 107 west road, Shandong, Ji'nan, China Applicant before: Zheng Tiancheng |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130821 Termination date: 20140617 |
|
EXPY | Termination of patent right or utility model |